HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Remission rates, survival, and prognostic factors in combination chemotherapy for bronchogenic carcinoma.

AuthorsP Alberto
JournalCancer chemotherapy reports. Part 3 (Cancer Chemother Rep 3) Vol. 4 Issue 2 Pg. 199-206 (Mar 1973) ISSN: 0069-0139 [Print] United States
PMID4729321 (Publication Type: Journal Article)
Chemical References
  • Procarbazine
  • Vincristine
  • Cyclophosphamide
  • Methotrexate
Topics
  • Carcinoma, Bronchogenic (drug therapy, mortality)
  • Cyclophosphamide (therapeutic use)
  • Humans
  • Lung Neoplasms (drug therapy, mortality)
  • Methotrexate (therapeutic use)
  • Neoplasm Metastasis
  • Procarbazine (therapeutic use)
  • Prognosis
  • Remission, Spontaneous
  • Retrospective Studies
  • Switzerland
  • Time Factors
  • Vincristine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: